Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms
NCT04734860
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
A different study will be conducted.
Conditions
Covid19
Interventions
BIOLOGICAL:
COVI-AMG
DRUG:
Placebo
Sponsor
Sorrento Therapeutics, Inc.